Literature DB >> 19051207

Sample size determination for constrained longitudinal data analysis.

Kaifeng Lu1, Devan V Mehrotra, Guanghan Liu.   

Abstract

The longitudinal data analysis model proposed by Liang and Zeger (Sankhyā: Indian J. Stat. Ser. B 2000; 62:134-148) uses the baseline as well as postbaseline values as the dependent variables, and the baseline mean responses are constrained to be the same across treatment groups due to randomization. Compared with the conventional longitudinal analysis of covariance, this approach can correctly estimate the variance of within-group mean changes and achieve the specified coverage probabilities. General results on the sample size and power calculations for this model in the presence of missing data are obtained. The sample size relationship between the constrained and unconstrained longitudinal data analysis is established. Simple expressions for sample size calculation are obtained for the compound symmetry and first-order autoregressive correlation structures. The sensitivity of the sample size requirement to the configuration of correlation structure and retention pattern is assessed. The performance of several ad hoc approximations for longitudinal data analysis sample size calculation is evaluated. Simulation studies are conducted to assess the validity of the proposed sample size formulas with deviation from normality. The sample size formulas are also illustrated in detail using real clinical trial data.

Entities:  

Mesh:

Year:  2009        PMID: 19051207     DOI: 10.1002/sim.3507

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.

Authors:  Hiromi Rakugi; Takuya Tsuchihashi; Kazuyuki Shimada; Hirotaka Numaguchi; Chisato Nishida; Hiroya Yamaguchi; Masayoshi Shirakawa; Kyoichi Azuma; Kenji P Fujita
Journal:  Hypertens Res       Date:  2015-02-26       Impact factor: 3.872

2.  MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial.

Authors:  Daniel O Clark; Huiping Xu; Lyndsi Moser; Philip Adeoye; Annie W Lin; Christy C Tangney; Shannon L Risacher; Andrew J Saykin; Robert V Considine; Frederick W Unverzagt
Journal:  Contemp Clin Trials       Date:  2019-07-18       Impact factor: 2.226

3.  Sample Size Calculations for Time-Averaged Difference of Longitudinal Binary Outcomes.

Authors:  Ying Lou; Jing Cao; Song Zhang; Chul Ahn
Journal:  Commun Stat Theory Methods       Date:  2016-02-18       Impact factor: 0.893

4.  Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease.

Authors:  Chengjie Xiong; Gerald van Belle; J Philip Miller; John C Morris
Journal:  Clin Trials       Date:  2011-02       Impact factor: 2.486

5.  A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data.

Authors:  Cuiling Wang; Charles B Hall; Mimi Kim
Journal:  Stat Methods Med Res       Date:  2012-02-21       Impact factor: 3.021

6.  To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials.

Authors:  Cynthia J Coffman; David Edelman; Robert F Woolson
Journal:  BMJ Open       Date:  2016-12-30       Impact factor: 2.692

7.  Repeated measures ASCA+ for analysis of longitudinal intervention studies with multivariate outcome data.

Authors:  Torfinn S Madssen; Guro F Giskeødegård; Age K Smilde; Johan A Westerhuis
Journal:  PLoS Comput Biol       Date:  2021-11-09       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.